4012:
The Use of Anti-Eosinophil Therapies for Allergic Diseases
Allergens/Allergy Testing/Allergy Therapeutics
Monday, March 5, 2018: 7:00 AM-8:00 AM
Hyatt, Convention Level, Celebration 13
1.00 CME/CE
Seminar
Primary Discussion Leaders:
Sameer K Mathur, MD PhD FAAAAI
Stephen T. Holgate, MD DSc FAAAAI
Enrico Heffler, MD PhD

Learning Objectives:
  1. Discuss data supporting the use of anti-IL5 medications for severe asthma
  2. Discuss the clinical trial data on the use of anti-eosinophil therapies for other eosinophilic diseases such as hypereosinophilic syndrome, nasal polyposis and eosinophilic esophagitis
Handouts
  • AAAAI Handout 2018.pdf (475.2 kB)
  • Printed Handout.pdf (601.6 kB)
  • See more of: Session